Clinical News Archive - Page 15 of 18

⚠️ Safety Alert

MHRA 26 Feb 2025

Letters and medicine recalls sent to healthcare professionals in January 2025

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. 

⚠️ Safety Alert

MHRA 13 Feb 2025

Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): review by two specialists is required for initiating valproate but not for male patients already taking valproate

Review by two specialists remains in place for patients initiating valproate under 55 years of age but the Commission on…

⚠️ Safety Alert

MHRA 28 Jan 2025

GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation

Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor…

⚠️ Safety Alert

MHRA 28 Jan 2025

Letters and medicine recalls sent to healthcare professionals in December 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices. 

⚠️ Safety Alert

MHRA 12 Dec 2024

Letters and medicine recalls sent to healthcare professionals in November 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

⚠️ Safety Alert

MHRA 06 Nov 2024

MedSafetyWeek November 2024: your Yellow Card report helps prevent future harm to others and improves patient safety

The ninth annual #MedSafetyWeek social media campaign is taking place 4 to 10 November 2024.

⚠️ Safety Alert

MHRA 06 Nov 2024

Letters and medicine recalls sent to healthcare professionals in October 2024

A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.

⚠️ Safety Alert

MHRA 24 Oct 2024

GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse

Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists…

⚠️ Safety Alert

MHRA 24 Oct 2024

Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme

We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives.

⚠️ Safety Alert

MHRA 24 Oct 2024

Bromocriptine: monitor blood pressure when prescribing bromocriptine for prevention or inhibition of post-partum physiological lactation

A safety review has been conducted by the MHRA following a Yellow Card report concerning a patient who was taking…

Clinical News

Join 10,000+ UK Clinicians